Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Transcriptional repression of MMP-1 by p21SNFT and reduced in vitro invasiveness of hepatocarcinoma cells

Oncogene volume 23, pages 8805–8814 (2004)Cite this article

Abstract

p21SNFT (21 kDa small nuclear factor isolated from T cells) is a human basic leucine zipper transcription factor that can repress AP-1-mediated transcription. We show here that overexpression of p21SNFT in HepG2 cells leads to repression of matrix metalloproteinase-1 by 70–80%. p21SNFT interacted with Jun at the matrix metalloproteinase-1 promoter −88 Ets/AP-1 enhancer element, where Jun is known to activate transcription via interaction with Fos and Ets proteins. When p21SNFT/Jun dimers bound the element in the presence of Ets, DNA was protected differently than when Fos was paired with Jun. The data suggest a difference in overall conformation between p21SNFT-containing and Fos-containing complexes that may be involved in the repression of matrix metalloproteinase-1 by p21SNFT. Overexpression of p21SNFT led to a reduction in invasiveness of HepG2 cells through type I collagen and reconstituted basement membrane, an effect similar to that obtained via direct immunodepletion of matrix metalloproteinase-1. The results indicate that the mechanism of repression of matrix metalloproteinase-1 by p21SNFT may be exploited in inhibiting pathological matrix remodeling during cancer progression in vivo.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Angel P, Baumann I, Stein B, Delius H, Rahmsdorf HJ and Herrlich P . (1987). Mol. Cell. Biol., 7, 2256–2266.

  • Blanc JF, Bisson C, Frankenne F, Noel A, Munaut C, Colige A, Collette J, Rosenbaum J and Foidart JM . (2002). Int. J. Oncol., 20, 1129–1136.

  • Borden P and Heller RA . (1997). Crit. Rev. Eukaryot. Gene Expr., 7, 159–178.

  • Bower KE, Zeller RW, Wachsman W, Martinez T and McGuire KL . (2002). J. Biol. Chem., 277, 34967–34977.

  • Buttice G, Duterque-Coquillaud M, Basuyaux JP, Carrere S, Kurkinen M and Stehelin D . (1996). Oncogene, 13, 2297–2306.

  • Chapman SC, Ayala JE, Streeper RS, Culbert AA, Eaton EM, Svitek CA, Goldman JK, Tavare JM and O’Brien RM . (1999). J. Biol. Chem., 274, 18625–18634.

  • Curran S and Murray GI . (1999). J. Pathol., 189, 300–308.

  • Curtiss VE, Smilde R and McGuire KL . (1996). Mol. Cell. Biol., 16, 3567–3575.

  • Fried MG . (1989). Electrophoresis, 10, 366–376.

  • Gutman A and Wasylyk B . (1990). EMBO J., 9, 2241–2246.

  • Iacobelli M, Wachsman W and McGuire K . (2000). J. Immunol., 165, 860–868.

  • Inoue T, Yashiro M, Nishimura S, Maeda K, Sawada T, Ogawa Y, Sowa M and Chung KH . (1999). Int. J. Mol. Med., 4, 73–77.

  • Ito T, Ito M, Shiozawa J, Naito S, Kanematsu T and Sekine I . (1999). Mod. Pathol., 12, 669–674.

  • Jonat C, Stein B, Ponta H, Herrlich P and Rahmsdorf HJ . (1992). Matrix Supp., 1, 145–155.

  • Kim JH, Kim TH, Jang JW, Jang YJ, Lee KH and Lee ST . (2001). Mol. Cells, 12, 32–40.

  • Matrisian LM . (1990). Trends Genet., 6, 121–125.

  • McGuire KL and Iacobelli M . (1997). J. Immunol., 159, 1319–1327.

  • Mengshol JA, Mix KS and Brinckerhoff CE . (2002). Arthritis Rheum., 46, 13–20.

  • Murray GI, Duncan ME, O’Neil P, McKay JA, Melvin WT and Fothergill JE . (1998). J. Pathol., 185, 256–261.

  • Murray GI, Duncan ME, O’Neil P, Melvin WT and Fothergill JE . (1996). Nat. Med., 2, 461–462.

  • Nagese H and Woessner Jr JF . (1999). J. Biol. Chem., 274, 21491–21494.

  • Nikolajczyk BS, Nelson B and Sen R . (1996). Mol. Cell. Biol., 16, 4544–4554.

  • Ozaki I, Zhao G, Mizuta T, Ogawa Y, Hara T, Kajihara S, Hisatomi A, Sakai T and Yamamoto K . (2002). J. Hepatol., 36, 169–178.

  • Siller-Lopez F, Garcia-Banuelos J, Hasty KA, Segura J, Ramos-Marquez M, Qoronfleh MW, Aguilar-Cordova E and Armendariz-Borunda J . (2000). J. Hepatol., 33, 758–763.

  • Sunami E, Tsuno N, Osada T, Saito S, Kitayama J, Tomozawa S, Tsuruo T, Shibata Y, Muto T and Nagawa H . (2000). Oncologist, 5, 108–114.

  • Tini M, Jewell UR, Camenisch G, Chilov D and Gassmann M . (2002). Comp. Biochem. Physiol. A, 131, 569–574.

  • Weinmann AS, Bartley SM, Zhang T, Zhang MQ and Farnham PJ . (2001). Mol. Cell. Biol., 21, 6820–6832.

  • Westermarck J, Steh A and Kahari V-M . (1997). Oncogene, 14, 2651–2660.

  • Westermark J and Kahari VM . (1999). FASEB J., 13, 781–792.

Download references

Acknowledgements

We thank Sara McBride and Tong Xu for isolation of chicken anti-p21SNFT #12 antiserum, Alicia Arroyo for technical assistance in Type I Collagen invasion assays, and Robert W Zeller and Michael Breindl for critical review of the manuscript. The pUC9pCllase II construct was kindly provided by Peter Angel, the his-Ets-1 DBD plasmid by Barbara Nikolajczyk, the Ets/AP-1CAT constructs by Richard O’Brien, and MMP-2 primers and chicken embryo fibroblast total RNA by Andreas Bader. This work was supported by AHA Predoctoral Fellowship #0215001Y and a Sigma Xi Grant-In-Aid (to KEB) and Cancer Research Program Grant 99-00542V-10051 (to KLM).

Author information

Author notes

  1. Jamie M Fritz

    Present address: Air Force Research Laboratory/HEPC, Brooks AFB, TX, 78235-5323, USA

Authors and Affiliations

  1. Department of Biology, San Diego State University, 5500 Campanile Drive, San Diego, 92182-4614, CA, USA

    Kristen E Bower, Jamie M Fritz & Kathleen L McGuire

  2. Molecular Biology Institute, San Diego State University, 5500 Campanile Drive, San Diego, 92182-4614, CA, USA

    Kristen E Bower & Jamie M Fritz

Authors
  1. Kristen E Bower
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jamie M Fritz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kathleen L McGuire
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kristen E Bower.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bower, K., Fritz, J. & McGuire, K. Transcriptional repression of MMP-1 by p21SNFT and reduced in vitro invasiveness of hepatocarcinoma cells. Oncogene 23, 8805–8814 (2004). https://doi.org/10.1038/sj.onc.1208109

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208109

Keywords

This article is cited by

Search

Advanced search

Quick links